merged_ftc-pharmacy-benefit-managers-drug-prices.txt
<question_number>1</question_number>
<answer>The FTC sharply criticized pharmacy benefit managers, saying they may be profiting by inflating drug costs and squeezing Main Street pharmacies.</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>The FTC report found that benefit managers often paid their own pharmacies much more than it would cost to buy those drugs from a wholesaler, translating into nearly $1.6 billion in revenue over less than three years for the biggest three conglomerates.</answer>